Chronic inflammatory diseases increase the risk of post-thrombotic syndrome: A prospective cohort study
European Journal of Internal Medicine · 2024
DOI: 10.1016/j.ejim.2023.10.014 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift European Journal of Internal Medicine, 2024. Verfasst von Aaron F J Iding und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands; Thrombosis Expertise Ce…. Hauptthemen laut MEDLINE: Venous Thrombosis, Venous Thromboembolism, Postthrombotic Syndrome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Clinical management of patients with deep vein thrombosis (DVT) is centered around their risk of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome (PTS). While chronic inflammatory disease (CID) has been established as a risk factor of (recurrent) VTE, research about its potential impact on PTS is lacking. OBJECTIVES: We aimed to assess the risk of PTS in patients with CID, stratifying for the use of anti-inflammatory treatment. PATIENTS/METHODS: Consecutive patients with proximal DVT and no active cancer between 2003 and 2018 received a two-year prospective follow-up. CID included inflammatory bowel disease, rheumatic diseases, and gout. Residual venous obstruction (RVO) was assessed by compressive ultrasound after 3-6 months. PTS was diagnosed using the Villalta score after 6-24 months. Hazard ratios (HR) and odds ratios (OR) were adjusted for patient characteristics. The medical ethics committee approved this study. RESULTS: In total 82 of 801 patients had CID (10.2 %). PTS more often developed in patients with CID (35.4% vs. 18.9 %, p < 0.001) than in those without CID (HR 1.72 [1.15-2.58]). The prevalence of RVO was similar in patients with and without CID (36.8% vs. 41.4 %), and RVO was strongly associated with PTS in patients with CID (OR 3.21 [1.14-9.03]). Moreover, patients with untreated CID (44 %, n = 36) more often had RVO than those with treated CID (51.6% vs. 26.7 %, p = 0.027), and accordingly had a higher risk of PTS (HR 2.18 [1.04-4.58]). CONCLUSIONS: Patients with CID had an increased risk of developing PTS, especially those without anti-inflammatory treatment, possibly due to an unfavorable impact on RVO-related venous pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands; Thrombosis Expertise Center, Heart+Vascular Center, Maastricht University Medical Center, Maa…
- Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Zitieren
APA
Iding, A. F. J., Limpens, T. M. P., Ten Cate, H., & Ten Cate-Hoek, A. J. (2024). Chronic inflammatory diseases increase the risk of post-thrombotic syndrome: A prospective cohort study. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2023.10.014
Vancouver
Iding AFJ, Limpens TMP, Ten Cate H, Ten Cate-Hoek AJ. Chronic inflammatory diseases increase the risk of post-thrombotic syndrome: A prospective cohort study. European Journal of Internal Medicine. 2024. doi:10.1016/j.ejim.2023.10.014
BibTeX
@article{Iding2024,
author = {Iding, Aaron F J and Limpens, Thibaut M P and Ten Cate, Hugo and Ten Cate-Hoek, Arina J},
title = {Chronic inflammatory diseases increase the risk of post-thrombotic syndrome: A prospective cohort study},
journal = {European Journal of Internal Medicine},
year = {2024},
doi = {10.1016/j.ejim.2023.10.014}
}
EUVIMED